Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm By Investing.com

New York, NY — (Newsfile Corp. – December 30, 2024) – Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors Akero Therapeutics, Inc. (NASDAQ: NASDAQ: breached their fiduciary duties to shareholders.The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reform.

If you long term Owner of AKRO shares please contact Justin Kuehn, Esq. here, Email justin@kuehn.law or call (833) 672-0814. The consultation and work is free with no obligation. Kuehn Law pays all case costs and does not charge its investing clients. Shareholders should contact the company immediately, as there may be a limited time to protect your rights.

Why is your participation important?

As a shareholder, your voice matters, and by getting involved, you contribute to the integrity and fairness of financial markets. Your contribution: Your voice. Your future.™

For more information, visit Shareholder Derivative Litigation – Kuehn Law.

Advertisement of a lawyer. Past results do not guarantee similar results.

To view the original version of this press release, visit https://www.newsfilecorp.com/release/235602